Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard E Gilbert

Showing results (91-100 of 173) with videos related to

Pageof 18
Sort By:
The American Journal of Medicine|August 27, 2017
Chronic Kidney Disease, Basal Insulin Glargine, and Health Outcomes in People with Dysglycemia: The ORIGIN StudyVasilios Papademetriou, Eric S Nylen, Michael Doumas, et al.
Clinical and Experimental Pharmacology & Physiology|July 9, 2011
Aliskiren increases bradykinin and tissue kallikrein mRNA levels in the heartDuncan J Campbell, Yuan Zhang, Darren J Kelly, et al.
Kidney International|March 11, 2011
Histone deacetylase inhibition attenuates diabetes-associated kidney growth: potential role for epigenetic modification of the epidermal growth factor receptorRichard E Gilbert, Qingling Huang, Kerri Thai, et al.
Diabetes Care|August 28, 2003
Urinary connective tissue growth factor excretion in patients with type 1 diabetes and nephropathyRichard E Gilbert, Aysel Akdeniz, Stephen Weitz, et al.
Physiological Reports|May 16, 2019
Impaired SIRT1 activity leads to diminution in glomerular endowment without accelerating age-associated GFR declineAshley R Bellin, Yanling Zhang, Kerri Thai, et al.
Journal of the American Society of Nephrology : JASN|February 13, 2009
PKC-beta1 mediates glucose-induced Akt activation and TGF-beta1 upregulation in mesangial cellsDongcheng Wu, Fangfang Peng, Baifang Zhang, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 20, 2004
Increased expression of urotensin II and urotensin II receptor in human diabetic nephropathyRobyn G Langham, Darren J Kelly, Renae M Gow, et al.
JACC. Basic to Translational Science|March 9, 2019
Empagliflozin Improves Diastolic Function in a Nondiabetic Rodent Model of Heart Failure With Preserved Ejection FractionKim A Connelly, Yanling Zhang, Aylin Visram, et al.
Heart, Lung & Circulation|September 19, 2012
Early and delayed tranilast treatment reduces pathological fibrosis following myocardial infarctionFiona See, Masataka Watanabe, Andrew R Kompa, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 11, 2003
Does vascular endothelial growth factor (VEGF) play a role in the pathogenesis of minimal change disease?Geoffrey Boner, Alison J Cox, Darren J Kelly, et al.
Pageof 18

Showing results (91-100 of 173) with videos related to

Sort By:
Pageof 18
The American Journal of Medicine|August 27, 2017
Chronic Kidney Disease, Basal Insulin Glargine, and Health Outcomes in People with Dysglycemia: The ORIGIN StudyVasilios Papademetriou, Eric S Nylen, Michael Doumas, et al.
Clinical and Experimental Pharmacology & Physiology|July 9, 2011
Aliskiren increases bradykinin and tissue kallikrein mRNA levels in the heartDuncan J Campbell, Yuan Zhang, Darren J Kelly, et al.
Kidney International|March 11, 2011
Histone deacetylase inhibition attenuates diabetes-associated kidney growth: potential role for epigenetic modification of the epidermal growth factor receptorRichard E Gilbert, Qingling Huang, Kerri Thai, et al.
Diabetes Care|August 28, 2003
Urinary connective tissue growth factor excretion in patients with type 1 diabetes and nephropathyRichard E Gilbert, Aysel Akdeniz, Stephen Weitz, et al.
Physiological Reports|May 16, 2019
Impaired SIRT1 activity leads to diminution in glomerular endowment without accelerating age-associated GFR declineAshley R Bellin, Yanling Zhang, Kerri Thai, et al.
Journal of the American Society of Nephrology : JASN|February 13, 2009
PKC-beta1 mediates glucose-induced Akt activation and TGF-beta1 upregulation in mesangial cellsDongcheng Wu, Fangfang Peng, Baifang Zhang, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 20, 2004
Increased expression of urotensin II and urotensin II receptor in human diabetic nephropathyRobyn G Langham, Darren J Kelly, Renae M Gow, et al.
JACC. Basic to Translational Science|March 9, 2019
Empagliflozin Improves Diastolic Function in a Nondiabetic Rodent Model of Heart Failure With Preserved Ejection FractionKim A Connelly, Yanling Zhang, Aylin Visram, et al.
Heart, Lung & Circulation|September 19, 2012
Early and delayed tranilast treatment reduces pathological fibrosis following myocardial infarctionFiona See, Masataka Watanabe, Andrew R Kompa, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 11, 2003
Does vascular endothelial growth factor (VEGF) play a role in the pathogenesis of minimal change disease?Geoffrey Boner, Alison J Cox, Darren J Kelly, et al.
Pageof 18